Healthcare AI Partnership: Microsoft and Mayo Clinic are building a “safe and trusted” AI model for healthcare, using Mayo’s medical knowledge and anonymised data to support earlier diagnosis and more personalised treatment planning. Rheumatology Updates: New EULAR 2026 data on dapirolizumab pegol in systemic lupus erythematosus points to lower flare rates and reduced long-term steroid exposure. Rare Disease Drug Pathway: Pharming says the U.S. FDA has accepted its resubmitted application for Joenja (leniolisib) for children aged 4–11 with APDS, with a decision target set for October 2026. Care Delivery Tech Funding: UK-based Semble (outpatient care coordination) raised £30m/€34.7m Series C led by Revaia to expand across UK and France and grow its AI orchestration layer. Patient Support in Practice: An Italian real-world study finds treat-to-target strategies in inflammatory rheumatic disease are being implemented inconsistently, with especially low adherence in spondyloarthritis. Workplace Wellbeing Policy: Kenya’s KWAL introduces paid “feminine leave” (one day per month) to support menstrual health and inclusion. Public Health & Mental Health Link: A review reports chronic constipation is associated with a higher likelihood of depression, highlighting gut-brain connections. Health Equity in Germany: Germany’s anti-discrimination agency saw a record rise in counselling requests in 2025, underscoring gaps in legal protection and support. Regulation Watch: France moves to crack down on CBD foods and flowers under EU “novel food” rules, tightening enforcement after years of grey-market tolerance.